Status:
COMPLETED
Cascade Genetic Testing of Familial Hypercholesterolemia
Lead Sponsor:
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Collaborating Sponsors:
Swiss Heart Foundation
Conditions:
Familial Hypercholesterolemia
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
Familial hypercholesterolemia (FH) is a frequent genetic disorder (1/200) associated with an increased risk of early-onset myocardial infarction. To improve detection and treatment of patient with FH,...
Eligibility Criteria
Inclusion
- patients with severe hypercholesterolemia and familial or personal history of early-onset cardiovascular disease = Dutch Lipid Clinic Network score (DLNC) \>= 6 points.
Exclusion
- Patients without at least one contactable first-degree family members
Key Trial Info
Start Date :
November 10 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
379 Patients enrolled
Trial Details
Trial ID
NCT04419090
Start Date
November 10 2020
End Date
December 31 2023
Last Update
January 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Center for primary care and public health (Unisanté), University of Lausanne
Lausanne, Switzerland, 1011